1004550-20-2 Usage
General Description
3-bromoimidazo[1,2-a]pyridine-6-carbaldehyde is a chemical compound with a molecular formula C8H5BrN2O. It is a highly reactive compound with a distinct chemical structure, containing a bromine atom and an aldehyde functional group. 3-bromoimidazo[1,2-a]pyridine-6-carbaldehyde has been used in various chemical reactions and organic synthesis processes due to its unique structure and reactivity. It has potential applications in the pharmaceutical industry for the development of new drugs and in the field of material science for the synthesis of novel materials. Additionally, this compound has also been studied for its biological activity and potential use as a building block in the synthesis of bioactive molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1004550-20-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,5,5 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1004550-20:
(9*1)+(8*0)+(7*0)+(6*4)+(5*5)+(4*5)+(3*0)+(2*2)+(1*0)=82
82 % 10 = 2
So 1004550-20-2 is a valid CAS Registry Number.
InChI:InChI=1S/C8H5BrN2O/c9-7-3-10-8-2-1-6(5-12)4-11(7)8/h1-5H
1004550-20-2Relevant articles and documents
THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS
-
Page/Page column 54-55, (2008/06/13)
Invented is a method of inhibiting the activity/function of PB kinases using thiozolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiozolidinedione derivatives.